Paweł Chmara

Mr. Paweł Chmara

Department of Pediatric Orthopedics and Traumatology, Poznan University of Medical Sciences
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2021 in Brain Sciences
Verified
Journal Article
Open access
PDF file
FMFaustyna Manikowska
Faustyna Manikowska
AKAnna Krzyżańska
Anna Krzyżańska
PCPaweł Chmara
Paweł Chmara
BCBrian Po-Jung Chen
Brian Po-Jung Chen
MJMarek Jóźwiak
Marek Jóźwiak
Robotic-assisted therapy (RAT) is a task-specific approach for treating gait disorders in individuals with neurological impairments. However, the effectiveness of RAT is not clear for different severities of involvement, pathologies, and ages. This study aimed to assess the functional and clinical status outcomes after RAT in individuals with cerebral palsy (CP). Twenty-eight individuals with bilateral spastic CP were enrolled (female = 10; male = 18; age = 15.2 ± 2.0 years). The RAT program consisted of 30 sessions: five sessions weekly for six weeks. Gross Motor Function Measure (GMFM) and clinical physical examinations were evaluated before and after RAT. Our results suggested that the RAT program with the described protocol can improve the general gross motor functions of individuals with CP in Gross Motor Function Classification System (GMFCS) levels I and II, and primarily improves performance on less complex GMFM items for those in GMFCS levels III and IV. The lower baseline functional level was related to a greater functional improvement. Older individuals were noticed to improve more in GMFM dimension D. Regarding impairments evaluated by clinical examinations, no change was found after RAT intervention. It is worth mentioning that the strength of knee muscles was not affected either.

29 June 2026 in Chirurgia Narządów Ruchu i Ortopedia Polska
Verified
Journal Article
Closed access
SBSabina Brazevic
Sabina Brazevic
ABAmadeusz Brzykcy
Amadeusz Brzykcy
PCPaweł Chmara
Paweł Chmara
RRRadosław Rutkowski
Radosław Rutkowski
MJMarek Jóźwiak
Marek Jóźwiak
Introduction. Gait disorders are a key determinant of functional capacity in ambulatory patients with spinal muscular atrophy (SMA), significantly affecting quality of life and fall risk. Three-dimensional clinical gait analysis (3DCGA) remains the gold standard for objective gait assessment, yet it is rarely applied in this population. Existing literature on SMA gait patterns is sparse and methodologically limited. Aim. To report the results of long-term observation of gait parameters changes over 18 months using 3DCGA-derived spatiotemporal parameters, Gait Deviation Index (GDI), or, when 3DCGA was not feasible – Edinburgh Visual Gait Score (EVGS) in patients with SMA who underwent robotic-assisted therapy. Materials and methods. A prospective longitudinal study was conducted between May 2024 and April 2026, with assessments at four time points (T1-T4) at six-month intervals. At baseline, 63 participants were enrolled (age 6.6 ± 4.6 years); 36 underwent 3DCGA, and 27 underwent EVGS assessment. Effect sizes (Cohen’s d) and paired t-tests were used to evaluate changes across intervals. Results. Walking speed and step length demonstrated progressive, statistically significant cumulative improvements relative to baseline, reaching d = 0.60 (p < 0.05) and d = 0.63 (p < 0.05) at T1→T4, respectively. GDI analysis revealed a consistent increase in the proportion of participants showing improvement (29% at T2, 32% at T3, 33% at T4) with a concurrent decline in deterioration and no evidence of change saturation. EVGS findings, available in a limited subset, are reported descriptively due to small sample sizes. Conclusions. The findings provide preliminary evidence of progressive gait improvement in ambulatory patients with SMA over 18 months, predominantly reflected in spatiotemporal parameters and GDI scores.

29 June 2026 in Chirurgia Narządów Ruchu i Ortopedia Polska
Verified
Journal Article
Closed access
MJMarek Jóźwiak
Marek Jóźwiak
ABAmadeusz Brzykcy
Amadeusz Brzykcy
SBSabina Brazevic
Sabina Brazevic
MRMagdalena Ratajczak
Magdalena Ratajczak
PCPaweł Chmara
Paweł Chmara
RRRadosław Rutkowski
Radosław Rutkowski
Introduction. Spinal muscular atrophy (SMA) is a progressive neuromuscular disorder in which primary motor neuron degeneration is accompanied by secondary skeletal complications, including impaired bone mineralisation and hip instability. Both conditions share overlapping pathophysiological mechanisms related to muscle weakness and reduced mechanical loading. Despite their clinical co-occurrence, the quantitative relationship between bone mineral density (BMD), expressed as a Z-score, and femoral head displacement, measured by the Reimers Migration Percentage (MP), has not been formally characterised across all three SMA subtypes within the same group. Aim. To characterise bone mineral density, hip migration and to describe the distribution of these parameters across SMA subtypes and in relation to motor function and functional capacity. Materials and methods. The study enrolled 77 patients with genetically verified SMA type 1 (n = 24), type 2 (n = 22), or type 3 (n = 31). Hip migration was assessed using the Reimers method (MP). Bone mineral density was determined by dual-energy X-ray absorptiometry (DXA) and reported as a Z-score. Motor performance was evaluated with the Gross Motor Function Measure (GMFM; dimensions D and E), the Revised Upper Limb Module (RULM), and the Hammersmith Functional Motor Scale (HFMS). Walking capacity was measured in 30 ambulatory patients using the 10-Metre Walk Test (10MWT), the Timed Up-and-Go test (TUG), and the 6-Minute Walk Test (6MWT). Two binary functional tests were additionally analysed: a 1-minute standing balance test and a 2-metre walk. Descriptive statistics are reported; inferential testing was limited to symmetry checks between paired measurements. Results. Mean BMD Z-score was –2.33 ± 1.17 (median –2.50; range -4.60 to 0.50). Mean MP was 0.40 ± 0.32 (median 0.32); 36.4% of patients had normal hip migration (≤ 25%), while 14.3% presented with complete dislocation (> 90%). A stepwise gradient was observed across SMA subtypes: type 1 showed the highest hip migration (median MP 0.690) and lowest BMD (median Z-score -3.050), followed by type 2 (0.365; –2.550) and type 3 (0.120; –1.500). Patients who passed the binary functional tests had markedly lower MP and higher Z-score than those who did not. Functional motor scores showed a clear subtype gradient: HFMS median 10.5 (type 1), 34.0 (type 2), and 40.0 (type 3); RULM median 18.0, 30.0, and 35.0, respectively. Among the 30 ambulatory patients, mean 10MWT completion time was 17.6 ± 16.9 s, mean TUG duration 16.8 ± 16.1 s (n = 29), and mean 6MWT distance 249 ± 170 m (n = 29). Conclusions. Impaired bone mineralisation and hip displacement co-occur in SMA across all three disease subtypes. These findings support integrating BMD monitoring and hip surveillance into routine clinical follow-up for all SMA subtypes, including type 1.